[Vasovagal syncope. Management with propanthelin bromide].
OBJECTIVE
To study propanthelin bromide efficacy in preventing vasovagal syncope relapse.


METHODS
HGZ No. 3 IMSS, Mazatlán, Sinaloa, México, from 1992 to 1995.


METHODS
10 patients with vasovagal syncope were selected from 41 syncope patients.


METHODS
Prospective longitudinal.


METHODS
clinical charts, neurologic and cardiologic evaluation, electrocardiogram, electroencephalogram, C.A.T., Holter, stress test and chest X rays were made. In 10 patients, 15 to 30 mg of propanthelin bromide thrice a day were administered, 12 month survey on was made measured.


RESULTS
Of the 10 patients, 7 were women mean age 18 years. In 9 of them no recurrence was evident abandoned 1 treatment, 4 had side effects.


CONCLUSIONS
Propanthelin bromide decreases vasovagal syncope episodes with few side effects.
Corbalá Fuentes
C
C
Hospital General de Zona No. 3., IMSS, Mazatlán, Sinaloa.
Pacheco Ureña
A
A
Pedraza Ibarra
S
S
Gárate Ureña
J A
JA
Manzano Miranda
L
L
Carrillo Camacho
A
A
Haro García
L
L
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use*; D011413:Propantheline / Q000627:therapeutic use*; D011446:Prospective Studies; D019462:Syncope, Vasovagal / Q000188:drug therapy*
D010276:Parasympatholytics; D011413:Propantheline